Europe PMC
Cure8 research brief
Why This Matters
The study suggests brain GLP-1 receptors may mediate intestinal anti-inflammatory effects of GLP-1R agonists in a mouse colitis model, which could inform future research into mechanisms and potential therapies for IBD.
Who Should Pay Attention
Researchers (GLP-1 biology, neuro-immune gut signaling, preclinical IBD models), clinicians and translational investigators interested in GLP-1RA mechanisms and new therapeutic targets
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study used diet-induced obese mice with dextran sodium sulfate (DSS)-induced colitis and compared peripheral versus intracerebroventricular (central) administration of semaglutide.
Both routes reduced colitis severity and histologic injury, and a low central dose produced benefits at levels too low to change food intake or body weight when given peripherally. These results suggest that GLP-1R signaling in the brain can be sufficient to reduce intestinal inflammation in this mouse model.
This is a preclinical animal study and does not establish safety or effectiveness in people with IBD.
Keep In Mind
Preclinical mouse study (DSS colitis); results are preliminary and not evidence of benefit or safety in humans. This is a preprint abstract-level report.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationEurope PMC
AuthorsDesai B, Francis KL, Bryan CL +14 more
Study typePreprint
Indexed viaEurope PMC
Source typeResearch paper
PublishedOct 24, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
TNF-α and IL-1β Antibodies Alongside Exogenous IL-10 Treatment Ameliorates DSS-Induced Colitis by Modulating the Apoptosis-Autophagy Pathways in Splenic Macrophages
The study tests combined neutralization of two pro-inflammatory cytokines plus IL‑10 in a mouse colitis model and reports reduced inflammation and restored macrophage cellular pathways, which may inform future IBD...
Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models.
The study investigates how specific gut bacterial strains can change colitis severity in experimental models — important because microbes are a focus of IBD research and potential therapies.
Prenylated p-Coumaric Acid Derivatives Mitigate Neurobehavioral and Neuroinflammatory Alterations Associated with Experimental Colitis.
The work links intestinal inflammation with neurobehavioral changes in a mouse colitis model and suggests certain p‑coumaric acid derivatives can reduce inflammation and anxiety/depression‑like behaviors, which could...